Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2025-12-24 @ 5:50 PM
NCT ID:
NCT01252368
Eligibility Criteria:
Inclusion criteria:
* Men and women aged 18-80 years
* BMI 18-35 kg/m2
* Group 1: patients taking daily RAS-active drugs, like ACE inhibitors or sartanes (treatment indication outside of this study)
* Group 2: no therapy with RAS-active drugs, like ACE inhibitors or sartanes Gastroduodenoscopy and/or colonoscopy with a treatment indication outside of this study
* Informed consent
Exclusion criteria:
* Severe pathologic alterations in the gastrointestinal tract (ulcers, tumors, celiac disease; GERD and gastritis are no exclusion criteria)
* Status after operations of the gastrointestinal tract (except uncomplicated appendectomy or inguinal hernia repair)
* Patients with malignant diseases
* Severe acute or chronic diseases which require treatment (e.g. renal replacement therapy)
* Patients with increased bleeding risk (e.g. oral anticoagulation, coagulopathy)
* Drug or alcohol abuse
* Mental disorders which limits the ability to fulfil all study requirements
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01252368
Study Brief:
Protocol Section:
NCT01252368